ATE312120T1 - Verfahren zur herstellung von konzentrierten menschlichen immunoglobulinen für die therapeutische verwendung - Google Patents
Verfahren zur herstellung von konzentrierten menschlichen immunoglobulinen für die therapeutische verwendungInfo
- Publication number
- ATE312120T1 ATE312120T1 AT02727688T AT02727688T ATE312120T1 AT E312120 T1 ATE312120 T1 AT E312120T1 AT 02727688 T AT02727688 T AT 02727688T AT 02727688 T AT02727688 T AT 02727688T AT E312120 T1 ATE312120 T1 AT E312120T1
- Authority
- AT
- Austria
- Prior art keywords
- therapeutic use
- human immunoglobulins
- producing concentrated
- concentrated human
- producing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0106234A FR2824568B1 (fr) | 2001-05-11 | 2001-05-11 | Procede de preparation de concentres d'immunoglobulines humaines a usage therapeutique |
| PCT/FR2002/001407 WO2002092632A1 (fr) | 2001-05-11 | 2002-04-24 | Procede de preparation de concentres d'immunoglobulines humaines a usage therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE312120T1 true ATE312120T1 (de) | 2005-12-15 |
Family
ID=8863163
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02727688T ATE312120T1 (de) | 2001-05-11 | 2002-04-24 | Verfahren zur herstellung von konzentrierten menschlichen immunoglobulinen für die therapeutische verwendung |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7186410B2 (de) |
| EP (1) | EP1385886B1 (de) |
| JP (1) | JP4445202B2 (de) |
| AT (1) | ATE312120T1 (de) |
| CA (1) | CA2446704C (de) |
| DE (1) | DE60207848T2 (de) |
| DK (1) | DK1385886T3 (de) |
| ES (1) | ES2254676T3 (de) |
| FR (1) | FR2824568B1 (de) |
| IL (2) | IL158893A0 (de) |
| WO (1) | WO2002092632A1 (de) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2853551B1 (fr) | 2003-04-09 | 2006-08-04 | Lab Francais Du Fractionnement | Formulation stabilisante pour compositions d'immunoglobulines g sous forme liquide et sous forme lyophilisee |
| FR2895263B1 (fr) * | 2005-12-26 | 2008-05-30 | Lab Francais Du Fractionnement | Concentre d'immunoglobines g (lg) appauvri en anticorps anti-a et anti-b, et en igg polyreactives |
| ES2409844T3 (es) * | 2006-01-30 | 2013-06-28 | Grifols Therapeutics Inc. | Metodo para el tratamiento y la profilaxis de enfermedades relacionadas con la deposicion de amiloide utilizando IgM |
| FR2899111B1 (fr) * | 2006-03-31 | 2010-09-03 | Lab Francais Du Fractionnement | Concentre d'immunoglobulines specifiques du chikungunya en tant que medicament. |
| FR2899112B1 (fr) | 2006-03-31 | 2010-09-03 | Lab Francais Du Fractionnement | Concentre d'immunoglobulines et de fragments f (ab)'2 et/ou fab specifiques d'un arbovirus en tant que medicament. |
| US8119104B2 (en) * | 2006-12-13 | 2012-02-21 | Michael R. Simon | Treatment of celiac disease with IgA |
| US7597891B2 (en) * | 2006-12-13 | 2009-10-06 | Simon Michael R | Synthesis of human secretory IgA for the treatment of Clostridium difficile associated diseases |
| US8709413B2 (en) | 2006-12-13 | 2014-04-29 | Michael R. Simon | Treatment of celiac disease with IgA |
| US7794721B2 (en) * | 2006-12-13 | 2010-09-14 | Simon Michael R | Synthesis of human secretory IgM and the treatment of clostridium difficile associated diseases herewith |
| FR2939667B1 (fr) | 2008-12-17 | 2012-01-27 | Fractionnement Et Des Biotechonologies Lab Franc | Composition d'immunoglobine g comme medicament pour le traitement de l'ictere neonatal par incompatibilite foetomaternelle dans le systeme abo |
| FR2940617B1 (fr) | 2008-12-30 | 2012-04-20 | Fractionnement Et Des Biotechonologies Lab Franc | Composition d'immunoglobulines g |
| BRPI1012082B1 (pt) | 2009-05-27 | 2022-08-16 | Takeda Pharmaceutical Company Limited | Método para preparar uma composição de igg concentrada a partir de plasma |
| FR2949195B1 (fr) | 2009-08-24 | 2011-10-14 | Lfb Biomedicaments | Poche de stockage de solution therapeutique |
| US8304248B2 (en) | 2009-11-16 | 2012-11-06 | Torres Anthony R | Protein separation via ion-exchange chromatography and associated methods, systems, and devices |
| FR2952826B1 (fr) | 2009-11-20 | 2012-04-06 | Lab Francais Du Fractionnement | Utilisation d'immunoglobulines polyvalentes pour traiter une cirrhose hepatique alcoolique ou metabolique |
| IT1397061B1 (it) | 2009-12-28 | 2012-12-28 | Kedrion Spa | Nuovo processo di purificazione su scala industriale di gammaglobuline da plasma umano per uso industriale. |
| GB201006753D0 (en) | 2010-04-22 | 2010-06-09 | Biotest Ag | Process for preparing an immunolobulin composition |
| US8772462B2 (en) | 2010-05-26 | 2014-07-08 | Baxter International Inc. | Removal of serine proteases by treatment with finely divided silicon dioxide |
| AU2010202125B1 (en) | 2010-05-26 | 2010-09-02 | Takeda Pharmaceutical Company Limited | A method to produce an immunoglobulin preparation with improved yield |
| US8796430B2 (en) | 2010-05-26 | 2014-08-05 | Baxter International Inc. | Method to produce an immunoglobulin preparation with improved yield |
| FR2961107B1 (fr) | 2010-06-15 | 2012-07-27 | Lab Francais Du Fractionnement | Composition d'immunoglobulines humaines stabilisee |
| FR2962650B1 (fr) | 2010-07-19 | 2013-04-05 | Lab Francais Du Fractionnement | Composition d'immunoglobulines humaines concentrees |
| FR2974301B1 (fr) * | 2011-04-20 | 2013-08-23 | Lab Francais Du Fractionnement | Procede de preparation d'un produit plasmatique deplete en un ou plusieurs facteurs thrombogenes |
| FR2977893B1 (fr) * | 2011-07-11 | 2015-02-20 | Lab Francais Du Fractionnement | Procede de preparation d'un concentre d'immunoglobulines polyvalentes |
| TWI629283B (zh) | 2012-02-23 | 2018-07-11 | 巴克斯歐塔公司 | 來自血漿中的免疫球蛋白之ｉ-ｉｖ-１部分沉澱 |
| EA201892521A1 (ru) | 2012-02-29 | 2019-07-31 | Баксалта Инкорпорейтид | РЕМИЕЛИНИЗАЦИЯ ПЕРИФЕРИЧЕСКИХ НЕРВОВ, СТИМУЛИРОВАННАЯ IgG |
| RU2644240C2 (ru) | 2012-03-09 | 2018-02-08 | Цсл Беринг Аг | Композиции, содержащие секреторноподобные иммуноглобулины |
| EP2636681A1 (de) * | 2012-03-09 | 2013-09-11 | CSL Behring AG | Verfahren zur Anreicherung von IgA |
| EP2636684A1 (de) | 2012-03-09 | 2013-09-11 | CSL Behring AG | Vorbeugung von Infektionen |
| SG11201505192RA (en) * | 2013-02-28 | 2015-08-28 | Agency Science Tech & Res | Chromatographic purification of antibodies from chromatin-deficient cell culture harvests |
| PT3395423T (pt) | 2013-03-14 | 2023-11-14 | Amgen Inc | Remoção de ligandos escapados de cromatografia de afinidade |
| KR20160012975A (ko) * | 2013-06-04 | 2016-02-03 | 에이전시 포 사이언스, 테크놀로지 앤드 리서치 | 단백질 정제 프로세스 |
| KR20160029840A (ko) * | 2013-07-05 | 2016-03-15 | 라보라토이레 프란카이즈 듀 프락티온네먼트 에트 데스 바이오테크놀로지스 | 친화성 크로마토그래피 매트릭스 |
| FR3018450B1 (fr) * | 2014-03-11 | 2016-04-15 | Lab Francais Du Fractionnement | Procede de preparation de proteines plasmatiques humaines |
| FR3035971A1 (fr) | 2015-05-07 | 2016-11-11 | Lab Francais Du Fractionnement | Composition enrichie en immunoglobulines polyclonales anti-a et/ou anti-b |
| CN105126100B (zh) * | 2015-09-23 | 2021-01-26 | 成都蓉生药业有限责任公司 | 一种富含IgM的人免疫球蛋白制剂及其制备方法 |
| EP3275897A1 (de) * | 2016-07-27 | 2018-01-31 | Biotest AG | Verfahren zur herstellung von immunoglobulinzusammensetzungen |
| FR3064484A1 (fr) | 2017-03-31 | 2018-10-05 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | Composition d'immunoglobulines utiles pour traiter des infections virales |
| FR3064486A1 (fr) | 2017-03-31 | 2018-10-05 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | Prevention d'une infection par le virus respiratoire syncytial dans les voies respiratoires superieures |
| FR3064485A1 (fr) | 2017-03-31 | 2018-10-05 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | Traitement d'une infection par le virus respiratoire syncytial |
| CN108101981B (zh) * | 2018-01-15 | 2019-06-04 | 四川远大蜀阳药业有限责任公司 | 一种静注免疫球蛋白的生产工艺 |
| FR3081328B1 (fr) | 2018-05-24 | 2021-01-01 | Lab Francais Du Fractionnement | Composition d'immunoglobulines humaines concentrees |
| CA3173539A1 (en) | 2020-03-31 | 2021-10-07 | Takeda Pharmaceutical Company Limited | A method to produce an immunoglobulin preparation from c-1 inhibitor depleted plasma |
| WO2025068923A2 (en) | 2023-09-26 | 2025-04-03 | Takeda Pharmaceutical Company Limited | IMMUNOGLOBULIN FORMULATIONS DEPLETED IN IgA |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4305870A (en) * | 1979-01-31 | 1981-12-15 | Immuno Aktiengesellschaft Fur Chemisch-Medizinische Produkte | Intravenous plasma derivatives and their production |
| US4272521A (en) * | 1979-07-16 | 1981-06-09 | Cutter Laboratories, Inc. | Purified immune serum globulin |
| DE3927112C1 (de) * | 1989-08-17 | 1990-10-25 | Biotest Pharma Gmbh, 6072 Dreieich, De | |
| DE3927111C3 (de) * | 1989-08-17 | 1994-09-01 | Biotest Pharma Gmbh | Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate |
| DK0447585T4 (da) * | 1990-03-22 | 2003-09-01 | Biotest Pharma Gmbh | Fremgangsmåde til fremstilling af et intravenøst tolerant immunglobulin-G-præparat |
| US5258177A (en) * | 1991-12-10 | 1993-11-02 | Alpha Therapeutic Corporation | IgA preparation and process of making the same |
| FR2706466B1 (fr) * | 1993-06-14 | 1995-08-25 | Aetsrn | Concentré d'immunoglobulines G à usage thérapeutique et procédé de production dudit concentré. |
| DE4424935C1 (de) * | 1994-07-14 | 1996-03-21 | Immuno Ag | Humanes virussicheres monomeres Immunglobulin A und Verfahren zu seiner Herstellung |
| US6150507A (en) * | 1995-03-23 | 2000-11-21 | Biopure Corporation | Method for producing a purified hemoglobin product |
| US6096872A (en) * | 1997-10-14 | 2000-08-01 | Ortho Diagnostic Systems, Inc. | Viral clearance process |
| JP4359352B2 (ja) * | 1997-10-23 | 2009-11-04 | 田辺三菱製薬株式会社 | 室温保存製剤 |
| ES2229784T3 (es) | 1998-06-09 | 2005-04-16 | Statens Serum Institut | Proceso de produccion de inmunoglobulinas para administracion intravenosa y otros productos de inmunoglobulina. |
-
2001
- 2001-05-11 FR FR0106234A patent/FR2824568B1/fr not_active Expired - Fee Related
-
2002
- 2002-04-24 JP JP2002589515A patent/JP4445202B2/ja not_active Expired - Fee Related
- 2002-04-24 EP EP02727688A patent/EP1385886B1/de not_active Expired - Lifetime
- 2002-04-24 CA CA2446704A patent/CA2446704C/fr not_active Expired - Fee Related
- 2002-04-24 ES ES02727688T patent/ES2254676T3/es not_active Expired - Lifetime
- 2002-04-24 AT AT02727688T patent/ATE312120T1/de active
- 2002-04-24 DK DK02727688T patent/DK1385886T3/da active
- 2002-04-24 WO PCT/FR2002/001407 patent/WO2002092632A1/fr not_active Ceased
- 2002-04-24 IL IL15889302A patent/IL158893A0/xx unknown
- 2002-04-24 DE DE60207848T patent/DE60207848T2/de not_active Expired - Lifetime
- 2002-04-24 US US10/476,771 patent/US7186410B2/en not_active Expired - Lifetime
-
2003
- 2003-11-16 IL IL158893A patent/IL158893A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1385886B1 (de) | 2005-12-07 |
| CA2446704C (fr) | 2013-09-24 |
| CA2446704A1 (fr) | 2002-11-21 |
| WO2002092632A1 (fr) | 2002-11-21 |
| AU2002257887A2 (en) | 2002-11-25 |
| FR2824568A1 (fr) | 2002-11-15 |
| FR2824568B1 (fr) | 2004-04-09 |
| DE60207848T2 (de) | 2006-08-17 |
| US7186410B2 (en) | 2007-03-06 |
| EP1385886A1 (de) | 2004-02-04 |
| DE60207848D1 (de) | 2006-01-12 |
| IL158893A0 (en) | 2004-05-12 |
| ES2254676T3 (es) | 2006-06-16 |
| JP4445202B2 (ja) | 2010-04-07 |
| IL158893A (en) | 2009-08-03 |
| DK1385886T3 (da) | 2006-04-18 |
| US20040132979A1 (en) | 2004-07-08 |
| JP2005500265A (ja) | 2005-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE312120T1 (de) | Verfahren zur herstellung von konzentrierten menschlichen immunoglobulinen für die therapeutische verwendung | |
| ATE278785T1 (de) | Neues verfahren zur gewinnung und reinigung von fusionsproteinen | |
| ATE278706T1 (de) | Verfahren zur konzentrierung von unlöslichen protein mittels filtration mit schwingenden membranen | |
| ATE252532T1 (de) | Verfahren zur herstellung von 3,3- dimethylbutyraldehyd durch oxidation von 3,3- dimethylbutanol | |
| DE69618485D1 (de) | Verfahren zur herstellung von epoxidierungskatalysatoren | |
| DE69516188D1 (de) | Verfahren zur herstellung von therephthalsäure | |
| ATE241012T1 (de) | Verfahren zur herstellung von humanen relaxin | |
| ATE382631T1 (de) | Verfahren zur herstellung von virusinaktiviertem humanem gammaglobulin g | |
| ATE393217T1 (de) | Verfahren zur reinigung von faktor-ix | |
| ATE316860T1 (de) | Verfahren zur automatischen herstellung von brillenlinsen | |
| DK1329462T3 (da) | Fremgangsmåde til fremstilling af human serumalbumin, som inddrager opvarmningstrin | |
| DE69903790D1 (de) | Verfahren zur herstelung von sojamilch | |
| DE60027932D1 (de) | Verfahren zur herstellung von proteinhydrolysaten | |
| ATE270275T1 (de) | Verfahren zur herstellung von 2-aryl-3-aryl-5- halogen-pyridinen, verwendbar als cox-2 inhibitoren | |
| DE69709655D1 (de) | Verfahren zur herstellung von 17-estern von 9alpha,21-dihalopregan-11beta,17alpha-diol-20-onen | |
| DE59607103D1 (de) | Verfahren zur gewinnung von 2-hydroxy-4-methylthiobuttersäure (mha) | |
| DE59712974D1 (de) | Verfahren zur Herstellung von Bonddrahtverbindungen | |
| DE69615843D1 (de) | Il-8 antagonisten zur behandlung von asthma | |
| DE69609054D1 (de) | Ein prozess für die herstellung von faktor ix biologischen ursprungs | |
| DE69510087D1 (de) | Verfahren zur herstellung von 5-chlor-2,3-dihydro-1h-inden-1-on | |
| DE69609140D1 (de) | Verfahren zur herstellung von einstückigen, komplexen bauteilen aus verbundwerkstoffen. | |
| DE69610421D1 (de) | Verfahren zur herstellung von alpha,beta-ungesättigten nitrilen | |
| DE59604543D1 (de) | Verfahren zur herstellung wässriger tensidkonzentrate | |
| DE69607565D1 (de) | Verfahren zur herstellung von ungesättigten cycloalifatischen ketonen | |
| EP0735140A3 (de) | Verfahren zur sekretische Proteinproduktion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1385886 Country of ref document: EP |